The role of somatostatin in GLP-1-induced inhibition of glucagon secretion in mice

The role of somatostatin in GLP-1-induced inhibition of glucagon secretion in mice Diabetologia (2017) 60:1731–1739 DOI 10.1007/s00125-017-4315-2 ARTICLE The role of somatostatin in GLP-1-induced inhibition of glucagon secretion in mice 1,2 1,2 Anne Ørgaard & Jens J. Holst Received: 7 March 2017 /Accepted: 10 April 2017 /Published online: 27 May 2017 The Author(s) 2017. This article is an open access publication Abstract +118.8%, respectively). Specific blockade of somatostatin re- Aims/hypothesis Glucagon-like peptide-1 (GLP-1) receptor ceptor 2 increased glucagon secretion (+118.8% at 1.5 mmol/l agonists are currently used for the treatment of type 2 diabetes. glucose and +162.9% at 6.0 mmol/l glucose) and completely Their main mechanism of action is enhancement of glucose- eliminated the inhibitory effect of GLP-1. induced insulin secretion (from increased beta cell glucose Conclusions/interpretation We have shown here that the sensitivity) and inhibition of glucagon secretion. The latter glucagon-lowering effect of GLP-1 is entirely mediated has been demonstrated to account for about half of their blood through the paracrine actions of somatostatin in the perfused glucose-lowering activity. Whereas the effect of GLP-1 on mouse pancreas. However, in this model, the inhibitory effect insulin secretion is clearly dependent on ambient glucose con- of GLP-1 was preserved at hypoglycaemic levels, leaving centrations and has been described in detail, the mechanism http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Diabetologia Springer Journals

The role of somatostatin in GLP-1-induced inhibition of glucagon secretion in mice

Loading next page...
 
/lp/springer_journal/the-role-of-somatostatin-in-glp-1-induced-inhibition-of-glucagon-5lnQpN85Oh
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine; Metabolic Diseases; Human Physiology
ISSN
0012-186X
eISSN
1432-0428
D.O.I.
10.1007/s00125-017-4315-2
Publisher site
See Article on Publisher Site

Abstract

Diabetologia (2017) 60:1731–1739 DOI 10.1007/s00125-017-4315-2 ARTICLE The role of somatostatin in GLP-1-induced inhibition of glucagon secretion in mice 1,2 1,2 Anne Ørgaard & Jens J. Holst Received: 7 March 2017 /Accepted: 10 April 2017 /Published online: 27 May 2017 The Author(s) 2017. This article is an open access publication Abstract +118.8%, respectively). Specific blockade of somatostatin re- Aims/hypothesis Glucagon-like peptide-1 (GLP-1) receptor ceptor 2 increased glucagon secretion (+118.8% at 1.5 mmol/l agonists are currently used for the treatment of type 2 diabetes. glucose and +162.9% at 6.0 mmol/l glucose) and completely Their main mechanism of action is enhancement of glucose- eliminated the inhibitory effect of GLP-1. induced insulin secretion (from increased beta cell glucose Conclusions/interpretation We have shown here that the sensitivity) and inhibition of glucagon secretion. The latter glucagon-lowering effect of GLP-1 is entirely mediated has been demonstrated to account for about half of their blood through the paracrine actions of somatostatin in the perfused glucose-lowering activity. Whereas the effect of GLP-1 on mouse pancreas. However, in this model, the inhibitory effect insulin secretion is clearly dependent on ambient glucose con- of GLP-1 was preserved at hypoglycaemic levels, leaving centrations and has been described in detail, the mechanism

Journal

DiabetologiaSpringer Journals

Published: May 27, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off